Acadia Healthcare (NASDAQ:ACHC – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.14, FiscalAI reports. The business had revenue of $895.31 million during the quarter, compared to analysts’ expectations of $877.76 million. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.58%. The business’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.72 EPS.
Acadia Healthcare Price Performance
Shares of NASDAQ ACHC traded up $2.53 during trading hours on Friday, hitting $37.32. 2,239,429 shares of the stock were exchanged, compared to its average volume of 2,835,602. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The company has a market cap of $3.47 billion, a PE ratio of -2.99, a price-to-earnings-growth ratio of 10.39 and a beta of 0.64. The company’s fifty day simple moving average is $29.27 and its two-hundred day simple moving average is $26.03. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $39.38.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on ACHC. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. UBS Group increased their price target on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Guggenheim raised their price objective on Acadia Healthcare from $39.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday. Leerink Partners upped their target price on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research report on Wednesday, September 23rd. Finally, KeyCorp increased their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $32.54.
Read Our Latest Report on ACHC
Trending Headlines about Acadia Healthcare
Here are the key news stories impacting Acadia Healthcare this week:
- Positive Sentiment: Q3 results topped expectations and full-year guidance was raised. Acadia reported adjusted earnings of $0.60 per share versus the $0.46 consensus and revenue of $895.3 million versus expectations of $877.8 million. Revenue grew 5.1% year over year, and the company raised its 2026 outlook—potentially supporting investor optimism about performance. Acadia Healthcare Q3 results and guidance
- Positive Sentiment: Analysts raised price targets. Guggenheim lifted its target to $41 and assigned a Buy rating. RBC raised its target to $41 from $31 while maintaining Outperform, signaling improved optimism about ACHC’s prospects. RBC price-target update
- Positive Sentiment: Operating trends showed continued revenue growth. Same-facility revenue rose 5.2%, with patient days up 1.1% and revenue per patient day up 4.0%. The earnings-call coverage also pointed to expectations for stronger growth ahead. Earnings-call highlights
- Neutral Sentiment: ACHC reached a 52-week high. This reflects strong recent momentum, though the report notes that future gains depend on whether fundamentals can sustain the rally. Zacks analysis of ACHC’s 52-week high
- Negative Sentiment: Profitability comparisons and some ratings temper the positive news. Q3 EPS was down from $0.72 a year earlier, and the supplied results report a negative net margin. Cantor Fitzgerald raised its target to $39 but kept a Neutral rating; Barclays raised its target to $35 and maintained Equal Weight, both below the recent share price. Q3 earnings report
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.
Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.
Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.
Read More
- Five stocks we like better than Acadia Healthcare
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
